Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Michael O'Riordan

January 18, 2021

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

一个比利时登记处的报告显示，在经股动脉TAVR中采取Sapien、CoreValve时的3年生存率结果相似

Yael L. Maxwell

June 03, 2015

News Daily News

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Yael L. Maxwell

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Daily News

Meta análisis: Los SLF son Beneficiosos pero podrían No salvar las Extremidades ni Mejorar la Supervivencia en Pacientes con EAP

May 03, 2013

News Daily News

Los Expertos Eligen los Avances Más Importantes de 2011

Jason Kahn

March 08, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

Advertisement

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

一个比利时登记处的报告显示，在经股动脉TAVR中采取Sapien、CoreValve时的3年生存率结果相似

Un Registro Belga Confirma una Supervivencia Similar a los 3 Años con las Válvulas Sapien y CoreValve en la realización de TAVR Transfemorales

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Meta análisis: Los SLF son Beneficiosos pero podrían No salvar las Extremidades ni Mejorar la Supervivencia en Pacientes con EAP

Los Expertos Eligen los Avances Más Importantes de 2011

Experts Give Their Picks for Most Important Developments of 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content